Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2026-02-20 @ 8:08 PM
Study NCT ID:
NCT01689532
Status:
COMPLETED
Last Update Posted:
2016-10-27
First Post:
2012-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine
Sponsor:
Janssen Pharmaceutical K.K.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Arthritis, Rheumatoid | View |